HTX President & CEO, HTX
John Soloninka has over 24 years of experience in medical technology consulting and company formation, growth and management. He graduated from Queen's University in engineering physics in 1981 and worked several years in aerospace engineering before earning an MBA, with distinction, from the University of London, England, in 1986. Over his career, he has led major projects in health system transformation, biopharma/device development and regulation, health IT, disease management, clinical trials, clinical genomics and venture capital for Price Waterhouse, Soloninka and Associates and IBM. Mr. Soloninka was a founder, senior executive and leader in startup companies in oncology, radiology and electronic medical records (EMR) and clinical trials that were variously sold to US firms Varian Medical Systems, Merge Technologies and Assistmed.
He came to HTX from his role as Healthcare Practice Lead for IBM Global Business Services in Ontario. He was appointed President and CEO of HTX in July 2010 and is currently a director and advisory board member of CIMTEC (the Centre for Imaging Technology and Commercialization), the Ontario Brain Institute (OBI), HTX, EXCITE, CHWP (Connected Health and Wellness Project), DFATD Life Sciences and Baycrest Centre.